Focus International

Production sites & Laboratories

Home
Production sites & Laboratories
Sites de production

Tit Mellil site

s
Tit Mellil
Covering an area of 20,000 m² and employing a third of the group's workforce (500 people), the Tit Mellil plant is specialised in the manufacture of solid, liquid and pasty products. It produces more than 45 million units annually.
It is GMP, BPF, AFSSAPS, Saudi FDA and Libya approved
MC Pharma

MC Pharma

Created in 2007, MC Pharma produces effervescent tablets in compliance with specific standards and conditions, such as the installation of a dry air system.
Cooper Pharma holds a strategic stake in MC Pharma.
COOPER PHARMA_0130
MC Pharma
Gynebio Pharma

Gynebio Pharma

Launched in 2019, Gynebio Pharma is the1st site dedicated to the manufacture of contraceptive hormones in Africa.
+90 years of experience
IDC Pharma

IDC Pharma

IDC PHARMA
cooperpharma
It's the Group's laboratory dedicated to Incremental Research and Development. Its mission is to develop galenic formulations:
Medicines with added-value formulations
« Generics plus »
Associations
CIPLA JV

CIPLA JV

Cooper Pharma is increasing its ownership in the Cipla Maroc joint venture from 15.8% to 24.9%. This strategic decision aims to strengthen Cooper Pharma's position as a leader in respiratory and central nervous system therapies, ensuring continued access to quality care for the Moroccan population.
+90 ans d'expérience
fr_FRFrench
en_USEnglish fr_FRFrench